Maciej Kmieciak

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy”.

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010294

N/A

0.510DataRank · unranked

16 citations

Xiaoyan Deng, Dipankar Bandyopadhyay, Michael O. Idowu, Taylor M. Jenkins, Maciej Kmieciak +16 more

A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors

Anti-Cancer Drugs(2024)10.1097/cad.0000000000001584

N/A

0.370DataRank · unranked

5 citations

Sarah Gordon, Sejal Kothadia, William P. McGuire, Leroy R. Thacker, Xiaoyan Deng +9 more

Phase I study of regorafenib and sildenafil in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3593

N/A

0DataRank · unranked

4 citations

Sarah Gordon, William P. McGuire, Leroy R. Thacker, Xiaoyan Deng, Mary Beth Tombes +5 more

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies

Cancer Chemotherapy and Pharmacology(2023)10.1007/s00280-023-04511-0

N/A

0DataRank · unranked

20 citations

Amanda Kagan, Michelle A. Rudek, Maciej Kmieciak, Mary Beth Tombes, Ellen Shrader +7 more

Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma

medRxiv(2024)10.1101/2024.04.23.24304634

N/A

0DataRank · unranked

4 citations

Palak Shah, Mary Beth Tombes, Ellen Shrader, Dipankar Bandyopadhyay, Xiaoyan Deng +8 more

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02125-x

N/A

0DataRank · unranked

7 citations

Lin Li, Jewel Nkwocha, Maciej Kmieciak, Shengzhe Shang, L. Ashley Cowart +13 more